
    
      PROTOCOL OUTLINE: This is a randomized, double-blind study. Participants are stratified by
      participating institution.

      Participants are randomly assigned to 1 of 2 treatment groups. The first group is treated
      with intravenous thyrotropin-releasing hormone (TRH) and intramuscular injections of
      betamethasone or dexamethasone. The second group receives a placebo in place of TRH.

      Postnatal therapy with surfactants, prophylactic steroids, and indomethacin is allowed.
    
  